Deerfield Partners, L.P., 10% Owner at Aclaris Therapeutics, Inc. (ACRS), sold 63,240 shares at $4.52 ($286K) on 2019-06-24, disclosed to the SEC on 2019-06-25.
Open-market sale of $286k ACRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.52 | 13,063 | $59K | 20.7% |
| 2 | $4.52 | 50,177 | $227K | 79.3% |
| Total | $4.52 avg | 63,240 | $286K | 100% |
| Filing → |
| BDTX | BUY | 2020-02-03 | $7.6M | — | Filing → |
| FIXX | SELL | 2020-01-31 | $16.0M | — | Filing → |
| ACRS | SELL | 2019-06-25 | $59K | — | Filing → |